Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement Study
Not Applicable
Recruiting
- Conditions
- Venous Thromboembolism
- Registration Number
- NCT05306821
- Lead Sponsor
- Marc Blondon
- Brief Summary
The primary objective is to evaluate and compare the short-term and medicum-term effectiveness of 2 types of interventions in 2 different hospitals to improve the adequacy of hospital thromboprophylaxis among acute medical inpatients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
- acute medical inpatients hospitalized at the Geneva University Hospitals or the Lugano Regional Hospitals
Exclusion Criteria
- patients already on therapeutic anticoagulation
- patients with an estimated life expectancy of <3 months
- pregnancy
- patients hospitalized for COVID-19
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Proportion of patients with an adequate thromboprophylaxis 90 days
- Secondary Outcome Measures
Name Time Method Incidence of major bleeding 90 days Incidence of venous thromboembolism 90 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do comprehensive electronic tools in medical charts improve thromboprophylaxis adherence in acute inpatients?
What is the comparative effectiveness of NCT05306821 interventions versus standard anticoagulant protocols in reducing VTE?
Which biomarkers predict optimal response to educational interventions in VTE risk stratification for medical inpatients?
How do non-pharmacological thromboprophylaxis strategies in NCT05306821 impact bleeding risks compared to traditional methods?
What combination approaches integrate electronic tools and anticoagulants to enhance VTE prevention in hospitalized patients?
Trial Locations
- Locations (2)
Geneva University Hospitals
🇨🇭Geneva, Switzerland
Ospedale Regionale di Lugano
🇨🇭Lugano, Switzerland
Geneva University Hospitals🇨🇭Geneva, Switzerland